RECRUITING

Peer Recovery to Improve Polysubstance Use and Mobile Telemedicine Retention

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to evaluate the feasibility and effectiveness of a peer-led, brief, behavioral intervention to improve adherence to medication for opioid use disorder (MOUD) and reduce polysubstance use among patients with OUD and polysubstance use in underserved areas. The intervention is based on behavioral activation (BA) and is specifically designed to be implemented by a trained peer recovery specialist. In this hybrid, Type-1 effectiveness-implementation randomized controlled trial (RCT), the investigators will evaluate the effectiveness and implementation of Peer Activate vs. treatment as usual (TAU) over twelve months.

Official Title

Peer-Delivered, Behavioral Activation Intervention to Improve Polysubstance Use and Retention in Mobile Telemedicine OUD Treatment in an Underserved, Rural Area

Quick Facts

Study Start:2023-06-15
Study Completion:2027-09-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05973838

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. Age 18 years or older
  2. Willing and able to provide informed consent
  3. Able to understand and follow study procedures
  4. Stable medical condition
  1. * Demonstrating active, unstable or untreated psychiatric symptoms, including mania and/or psychosis that would interfere with study participation
  2. * Inability to understand the study and provide informed consent in English

Contacts and Locations

Study Contact

Morgan S Anvari, BA
CONTACT
3014055095
manvari@umd.edu

Principal Investigator

Jessica F Magidson, PhD
PRINCIPAL_INVESTIGATOR
University of Maryland, College Park
Sarah M Kattakuzhy, MD
PRINCIPAL_INVESTIGATOR
University of Maryland, Baltimore

Study Locations (Sites)

HIPS Clinic
Washington D.C., District of Columbia, 20002
United States
University of Maryland Baltimore (UMD Drug Treatment Center)
Baltimore, Maryland, 21223
United States
University of Maryland, College Park
College Park, Maryland, 20742
United States
Caroline County Behavioral Health
Denton, Maryland, 21629
United States

Collaborators and Investigators

Sponsor: University of Maryland, College Park

  • Jessica F Magidson, PhD, PRINCIPAL_INVESTIGATOR, University of Maryland, College Park
  • Sarah M Kattakuzhy, MD, PRINCIPAL_INVESTIGATOR, University of Maryland, Baltimore

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-06-15
Study Completion Date2027-09-01

Study Record Updates

Study Start Date2023-06-15
Study Completion Date2027-09-01

Terms related to this study

Keywords Provided by Researchers

  • Substance-Related Disorders
  • Opioid-Related Disorders
  • Polysubstance Use
  • Mental disorders

Additional Relevant MeSH Terms

  • Polysubstance Addiction
  • Opioid Medication Assisted Treatment
  • Treatment Adherence
  • Retention in Care
  • Substance-Related Disorders